Galena Biopharma Reaches $20M Settlement In Securities Lawsuits

(December 11, 2015, 11:05 AM EST) -- PORTLAND, Ore. — Galena Biopharma Inc. will pay $20 million to settle claims in both a securities class action lawsuit and a shareholder derivative lawsuit alleging that the company and certain...
To view the full article, register now.